Bristol Myers Squibb (NYSE:BMY) today announced that Opdivo (nivolumab) (injection for intravenous use), in combination with fluoropyrimidine- and platinum-containing chemotherapy, was approved by the U.S.

-SEC Filing  https://www.sec.gov/Archives/edgar/data/1496963/000110465921051251/tm213918-6_s1.htm

CoreCivic, Inc. (NYSE:CXW) ("CoreCivic") announced today that it has reached an agreement in principle to settle a purported securities class action lawsuit filed on August 23, 2016, against CoreCivic and

Akers Biosciences, Inc. ("Akers") (NASDAQ:AKER) and MyMD Pharmaceuticals, Inc. ("MYMD") today announced that at Akers' special meeting of stockholders held on April 15, 2021, Akers obtained sufficient votes for each proposal required to consummate the previously announced proposed merger between Akers and MYMD.

-Bloomberg

Square (SQ) - 409,241 Shares Syros Pharmaceuticals (SYRS) - 5,871 Pluristem Therapeutics (PSTI) - 399 Phreesia (PHR) - 44,762 PACCAR (PCAR) - 130,441 Intercontinental Exchange (ICE) - 209,161 Teradyne (TER) -

Coinbase Global (COIN) - 341,186 Shares 908 Devices (MASS) - 5,487 Beam Therapeutics (BEAM) - 2,050 Exact Sciences (EXAS) - 28,354 Unity Software (U) - 250,400 TuSimple (TSP) - 3,079,032 Iridium Communications